Latest Kaiser Health News Stories
Some of the nation’s most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
Even if the Republican from Maine can get her party to go along, her suggestions to bolster the individual insurance market may be too little, too late.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Congress let funding for the Children’s Health Insurance Program expire in September, and despite bipartisan support for the program, states are facing the specter of having to prepare to wind down their programs.
The sticking point is not whether to keep the popular Children’s Health Insurance Program running but how best to raise the cash.
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
Medicare officials have been discussing a rule change that would give beneficiaries a share of the secretive fees and discounts that are negotiated for prescription drugs.
About 9 million people claimed about $87 billion in medical deductions in 2015.
House Republicans want to repeal federal tax credits that have helped spur a boom in orphan drugs for rare diseases.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the start of open enrollment under the Affordable Care Act, legislative efforts on Capitol Hill on taxes and children’s health insurance, and recommendations of the president’s opioid commission.
The Vermont senator found a friendly audience when he took his “Medicare-for-all message” to Canada.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Alice Ollstein of Talking Points Memo discuss the bipartisan plan in the Senate to stabilize the individual insurance exchanges, and President Donald Trump’s mixed messages about his support or lack thereof.
The bipartisan accord would restore funding for the cost-sharing reductions that President Donald Trump ended last week and would give states more flexibility to devise alternatives for providing and subsidizing health care.
Eight teaching centers in California aim to train and retain doctors in medically underserved areas such as California’s Central Valley. They are among 57 such institutions across the country that may soon receive a boost in funding from Congress.
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of The Wall Street Journal, Margot Sanger-Katz of The New York Times, and Joanne Kenen of Politico discuss Congress’ tardiness in renewing the Children’s Health Insurance Plan (CHIP), and play the parlor game of who might become the new secretary of Health and Human Services. Also, the pod panel interviews Rep. John Larson (D-Conn.) about his new Medicare buy-in bill.
Federal funding for the Children’s Health Insurance Program expired Sept. 30. Many states still have money in their budgets, but they’ll be worried until Congress renews the program.
Tom Price resigned from running the Department of Health and Human Services after a series of news stories detailing how he tallied more than $400,000 in private plane travel paid for by taxpayers.
At a political rally in March, President Donald Trump said drug prices are “outrageous” and blamed campaign contributions. Drugmakers funneled nearly $280,000 to Congress the very next day.
The clinics, which serve many poor people, are tightening spending in case Congress doesn’t approve new funding for them before the government’s 2018 fiscal year starts Sunday.